Literature DB >> 15679098

Upregulation of connexin43 gap junctions between neointimal smooth muscle cells.

Gabriele Plenz1, Yu-shien Ko, Hung-I Yeh, Heike Eschert, Jürgen R Sindermann, Anja Dorszewski, Oliver Hofnagel, Horst Robenek, Günther Breithardt, Nicholas J Severs.   

Abstract

Increased expression of connexin43 gap junctions in smooth muscle cells (SMC) is implicated in the response to primary arterial injury and in the early stages of human coronary atherosclerosis, but the relevance of these findings to restenosis is unknown. Here we investigated the expression of connexin43 gap junctions in restenotic aortas of cholesterol-fed double injured rabbits. Immunofluorescence confocal microscopy was used to evaluate temporal and spatial expression patterns and to characterize the major expressing cell type. Parallel studies were conducted by electron microscopy, in situ hybridization and Northern blot analysis. Connexin43 gap junctions- and connexin43 mRNA-expressing cells were abundant in the media of non-injured control aorta. Following primary injury and 6 weeks cholesterol diet, connexin43 gap junctions were found distributed throughout the primary intimal layer; although medial expression was reduced, the overall mRNA expression level remained similar to that of non-injured controls. After secondary injury, no major change in distribution pattern of connexin43 gap junctions occurred up to day 10, when marked neointimal labeling was observed. This overall pattern persisted, though with some diminution, at later stages. On the mRNA level total connexin43 mRNA expression declined to about 40% of control values within 4 days after secondary injury (P < 0.05), but subsequently increased four-fold, attaining levels double that of non-injured controls in the 10-day group (P < 0.005 versus control and 4 days). At later stages mRNA expression levels returned to values similar to those of non-injured controls. At all stages, connexin43 gap junctions were localized to the SMC, not to macrophages. We conclude that the enhanced gap junction formation may contribute to the coordination of the response of SMC after secondary injury, particularly in the early phase of restenosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15679098     DOI: 10.1078/0171-9335-00417

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  5 in total

Review 1.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

2.  MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation.

Authors:  Scott R Johnstone; Brett M Kroncke; Adam C Straub; Angela K Best; Clarence A Dunn; Leslie A Mitchell; Yelena Peskova; Robert K Nakamoto; Michael Koval; Cecilia W Lo; Paul D Lampe; Linda Columbus; Brant E Isakson
Journal:  Circ Res       Date:  2012-05-31       Impact factor: 17.367

3.  Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway.

Authors:  Guanghong Jia; Gang Cheng; Deepak M Gangahar; Devendra K Agrawal
Journal:  J Mol Cell Cardiol       Date:  2008-03-12       Impact factor: 5.000

Review 4.  Connexins in vascular physiology and pathology.

Authors:  Anne C Brisset; Brant E Isakson; Brenda R Kwak
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

5.  Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia.

Authors:  Alban Longchamp; Florent Allagnat; Florian Alonso; Christopher Kuppler; Céline Dubuis; Charles-Keith Ozaki; James R Mitchell; Scott Berceli; Jean-Marc Corpataux; Sébastien Déglise; Jacques-Antoine Haefliger
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.